Researchers may have found a new target in chronic obstructive pulmonary disease (COPD) symptoms that could potentially save more lives. The study focused on mucus plugs, which clog airways in the ...
A retrospective analysis of patient data from the COPDGene study suggests that targeting mucus plugs could help prevent deaths from chronic obstructive pulmonary disease—the fourth leading cause of ...
Please provide your email address to receive an email when new articles are posted on . More adults with COPD and mucus plugs died vs. adults with COPD and no mucus plugs. A heightened mortality risk ...
WASHINGTON -- Mucus plugs obstructing the airways of patients with chronic obstructive pulmonary disease (COPD) were associated with higher all-cause mortality compared with no mucus plugs, according ...
Please provide your email address to receive an email when new articles are posted on . Patients with COPD and mucus plugs observed on both a baseline and 5-year follow-up CT scan vs. no mucus plugs ...
A retrospective analysis of patient data from the COPDGene study suggests that targeting mucus plugs could help prevent deaths from chronic obstructive pulmonary disease - the fourth leading cause of ...
(Boston)—Chronic obstructive pulmonary disease (COPD) affects approximately 29 million people in the U.S. and is the fourth leading cause of death. Mucus plugging (mucus that accumulates in the lungs ...
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, most often caused by cigarette smoking or long-term exposure to air pollutants. While there is ...
This year’s most-read articles on chronic obstructive pulmonary disease (COPD) explored a variety of topics concerning patients with COPD, including long-acting inhaler adherence and their risk of ...
Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage to the airways. It typically refers to emphysema and chronic bronchitis.
CHAPEL HILL, N.C. & MIAMI--(BUSINESS WIRE)--Renovion and COPD Foundation Joint Release – Renovion, Inc. has announced that the first patient has been enrolled in a Phase 2 clinical study evaluating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback